CELESTONE SOLUSPAN is a Intra-articular; Intralesional; Intramuscular; Soft Tissue Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Betamethasone Acetate; Betamethasone Sodium Phosphate.
| Product ID | 0085-4320_21506ad3-4b4e-4052-b848-8620c428fcbc |
| NDC | 0085-4320 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CELESTONE SOLUSPAN |
| Generic Name | Betamethasone Acetate And Betamethasone Sodium Phosphate |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE |
| Marketing Start Date | 2017-03-02 |
| Marketing Category | NDA / NDA |
| Application Number | NDA014602 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE |
| Active Ingredient Strength | 3 mg/mL; mg/mL |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |